Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
second_navbar.gif (585 bytes)
 
Research

Persistence and variability of Stenotrophomonas maltophilia in Cystic Fibrosis Patients, Madrid, 1991-1998

Sylvia Valdezate,*,† Ana Vindel,† Luis Maiz,* Fernando Baquero,* Hector Escobar,* and Rafael Cantón*
*Hospital Ramón y Cajal, Madrid, Spain; †Centro Nacional de Microbiología, Instituto Carlos III, Madrid, Spain

Figure 5. Pulsed-field gel electrophoresis pattern of XbaI-digested genomic DNA of Stenotrophomonas maltophilia isolates from two SM-RE patients. Lanes 1-10 from patient 1 (persistence group): pattern 1a (lanes 1,3-6,8), pattern 1b (ln 7), pattern 1c (lane 9) and pattern 2 (lane 2); lanes 10-15 from patient 5 (variability group): pattern 3 (lane 10), pattern 4 (lane 11,12), pattern 5 (lane 13), pattern 6 (lane 14), pattern 7 (lane 15). Lanes M, bacteriophage lambda standard marker.

Back to article
Figure 5. Pulsed-field gel electrophoresis pattern of XbaI-digested genomic DNA of Stenotrophomonas maltophilia isolates from two SM-RE patients. Lanes 1-10 from patient 1 (persistence group): pattern 1a (lanes 1,3-6,8), pattern 1b (ln 7), pattern 1c (lane 9) and pattern 2 (lane 2); lanes 10-15 from patient 5 (variability group): pattern 3 (lane 10), pattern 4 (lane 11,12), pattern 5 (lane 13), pattern 6 (lane 14), pattern 7 (lane 15). Lanes M, bacteriophage lambda standard marker.
 

Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed February 20, 2001

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention